BOSTON — Researchers at Massachusetts General Hospital (MGH) have discovered that the interferon gamma receptor (IFNgR) signaling pathway is critical for susceptibility of glioblastoma tumors to ...

Impact of protracted venous infusion fluorouracil with or without interferon alfa-2b on tumor response, survival, and quality of life in advanced colorectal cancer. The primary goal of this study was ...

nm23 in ovarian cancer: correlation with clinical outcome and other clinicopathologic and biochemical prognostic parameters. Of 98 assessable patients, 31 (32%) achieved a surgically documented ...

T cells have long been studied for their ability to target and eliminate tumor cells. In order for the T cells to do so, the tumors must express antigens not presented by healthy tissues, and the ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window In a small ...

Multiple system atrophy is a rare and fatal neurodegenerative disease, where insoluble inclusions of the protein alpha-synuclein appear in oligodendrocyte cells of the brain. The resulting ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio A single dose of pegylated interferon ...

-- To divest Actimmune for $55 million in cash plus a two-year royalty stream -- -- Transaction provides additional financial flexibility -- BRISBANE, Calif., May 21, 2012 /PRNewswire via COMTEX/ -- ...

Horizon Pharma said today it will acquire rights to interferon gamma-1b outside of North America and Japan from Boehringer Ingelheim for €25 million ($28 million). The deal gives Horizon Pharma global ...

Researchers have discovered that the interferon gamma receptor (IFNgR) signaling pathway is critical for susceptibility of glioblastoma tumors to killing by CAR T-cell immunotherapy. Researchers at ...